Samir Agrawal

10.6k total citations · 1 hit paper
79 papers, 3.5k citations indexed

About

Samir Agrawal is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Samir Agrawal has authored 79 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 21 papers in Epidemiology and 21 papers in Immunology. Recurrent topics in Samir Agrawal's work include Chronic Lymphocytic Leukemia Research (18 papers), Antifungal resistance and susceptibility (18 papers) and Fungal Infections and Studies (16 papers). Samir Agrawal is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Antifungal resistance and susceptibility (18 papers) and Fungal Infections and Studies (16 papers). Samir Agrawal collaborates with scholars based in United Kingdom, United States and France. Samir Agrawal's co-authors include John G. Gribben, Heather Oakervee, Jamie Cavenagh, Li Jia, Fengting Liu, Kalyanmoy Deb, David Taussig, Debra M. Lillington, Rewas Fatah and Alan G. Ramsay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Samir Agrawal

73 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

2016 432 citations Frédéric Tissot, Samir Agrawal et al. Haematologica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samir Agrawal United Kingdom	29	1.0k	924	873	856	781	79	3.5k
Christian M. Schürch Switzerland	30	1.5k 1.5×	1.1k 1.2×	1.4k 1.6×	707 0.8×	266 0.3×	89	3.9k
Qifa Liu China	40	1.3k 1.3×	1.3k 1.5×	1.3k 1.5×	3.2k 3.7×	286 0.4×	357	5.7k
Borna Mehrad United States	46	1.1k 1.1×	1.0k 1.1×	2.0k 2.2×	297 0.3×	1.4k 1.8×	131	6.4k
Duck Cho South Korea	29	464 0.5×	1.0k 1.1×	1.3k 1.5×	545 0.6×	635 0.8×	205	3.0k
Anne Bergeron France	44	912 0.9×	755 0.8×	469 0.5×	705 0.8×	1.6k 2.1×	185	5.7k
Takanori Ueda Japan	31	1.5k 1.5×	642 0.7×	403 0.5×	675 0.8×	206 0.3×	310	4.1k
Heng Mei China	25	807 0.8×	1.1k 1.1×	557 0.6×	435 0.5×	471 0.6×	169	2.9k
Yoko Tabe Japan	31	1.3k 1.3×	541 0.6×	526 0.6×	936 1.1×	205 0.3×	165	3.0k
Gerard Lozanski United States	43	1.5k 1.5×	1.7k 1.9×	1.6k 1.9×	1.2k 1.4×	512 0.7×	176	6.4k
Jing Chen China	29	969 0.9×	971 1.1×	651 0.7×	1.1k 1.3×	116 0.1×	172	3.1k

Countries citing papers authored by Samir Agrawal

Since Specialization

Citations

This map shows the geographic impact of Samir Agrawal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Agrawal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Agrawal more than expected).

Fields of papers citing papers by Samir Agrawal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Agrawal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Agrawal. The network helps show where Samir Agrawal may publish in the future.

Co-authorship network of co-authors of Samir Agrawal

This figure shows the co-authorship network connecting the top 25 collaborators of Samir Agrawal. A scholar is included among the top collaborators of Samir Agrawal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir Agrawal. Samir Agrawal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnstone, Peter A.S., et al.. (2025). De‐diagnosing chronic lymphocytic leukaemia: An ethical and scientific case for changing diagnostic criteria. HemaSphere. 9(11). e70252–e70252.

Schelenz, Silke, Samir Agrawal, A. J. Brady, et al.. (2024). Antifungal stewardship in the UK: where are we now?. JAC-Antimicrobial Resistance. 7(1). dlae209–dlae209.

Abdolrasouli, Alireza, et al.. (2024). Invasive Sino-Orbital Aspergillosis and Tinea Corporis Co-Infection in a Returned Traveler from Flooded Sylhet, Bangladesh. American Journal of Tropical Medicine and Hygiene. 112(1). 150–152. 1 indexed citations

Mathur, Anthony, Doo Sun Sim, Fizzah Choudry, et al.. (2022). Five-Year Follow-Up of Intracoronary Autologous Cell Therapy in Acute Myocardial Infarction: The REGENERATE-AMI Trial. ESC Heart Failure. 9(2). 1152–1159. 12 indexed citations

Farren, Timothy, et al.. (2020). Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay. Frontiers in Oncology. 10. 597730–597730. 8 indexed citations

Wang, Huaqing, et al.. (2019). Increased autocrine interleukin‐6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia. Journal of Cellular Physiology. 234(8). 13994–14006. 21 indexed citations

Agrawal, Samir, et al.. (2019). A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma). Frontiers in Pharmacology. 10. 681–681. 13 indexed citations

Agrawal, Samir, Rosemary A. Barnes, Roger J. M. Brüggemann, Riina Rautemaa‐Richardson, & Adilia Warris. (2016). The role of the multidisciplinary team in antifungal stewardship. Journal of Antimicrobial Chemotherapy. 71(suppl 2). ii37–ii42. 41 indexed citations

Tissot, Frédéric, Samir Agrawal, Livio Pagano, et al.. (2016). ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica. 102(3). 433–444. 432 indexed citations breakdown →

10.

Liu, Fengting, Li Jia, Ping Wang, et al.. (2015). CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(10). 2462–2469. 15 indexed citations

11.

Johnson, Gemma, Shah‐Jalal Sarker, Francesco Nannini, et al.. (2015). Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis. Journal of Clinical Microbiology. 53(7). 2103–2108. 38 indexed citations

12.

Hamshere, Stephen, Samer Arnous, Tawfiq Choudhury, et al.. (2015). Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. European Heart Journal. 36(44). 3061–3069. 67 indexed citations

13.

Miraki‐Moud, Farideh, Fernando Anjos‐Afonso, Katharine Hodby, et al.. (2013). Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation. Proceedings of the National Academy of Sciences. 110(33). 13576–13581. 108 indexed citations

14.

Mozid, Abdul, Daniel A. Jones, Samer Arnous, et al.. (2012). The Effects of Age, Disease State, and Granulocyte Colony-Stimulating Factor on Progenitor Cell Count and Function in Patients Undergoing Cell Therapy for Cardiac Disease. Stem Cells and Development. 22(2). 216–223. 18 indexed citations

15.

Agrawal, Samir, B Jones, Rosemary A. Barnes, et al.. (2012). A practical critique of antifungal treatment guidelines for haemato-oncologists. Critical Reviews in Microbiology. 38(3). 203–216. 7 indexed citations

16.

Lambourne, Jonathan, Dan Agranoff, Raoul Herbrecht, et al.. (2009). Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients. Clinical Infectious Diseases. 49(10). 1486–1491. 61 indexed citations

17.

Liu, Fengting, Samir Agrawal, Zanyar Movasaghi, et al.. (2008). Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood. 112(9). 3835–3846. 72 indexed citations

18.

Taussig, David, Farideh Miraki‐Moud, Fernando Anjos‐Afonso, et al.. (2008). Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 112(3). 568–575. 278 indexed citations

19.

Oakervee, Heather, Rakesh Popat, Nicola Curry, et al.. (2005). PAD combination therapy (PS‐341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma. British Journal of Haematology. 129(6). 755–762. 235 indexed citations

20.

Agrawal, Samir, et al.. (1994). First report of fludarabine in gamma‐heavy chain disease. British Journal of Haematology. 88(3). 653–655. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact